Jay Mei
Founder, Chairman & Chief Executive Officer Antengene
Jay Mei is Founder, Chairman, and Chief Executive Officer of Antengene, a global biopharmaceutical company focused on developing and commercializing innovative oncology therapies across Asia and worldwide. He has more than two decades of experience in the pharmaceutical industry, including leadership roles at Celgene, where he played a central role in expanding the company’s presence in Asia and advancing multiple oncology assets. At Antengene, Jay has led the company from inception through clinical development and commercialization, building a diversified pipeline and global partnership network.
Seminars
Thursday 10th September 2026
What can be Improved Upon for Existing Drugs?
8:45 am
- Discussing approaches to differentiate assets targeting competitive targets
- With clinical data so far, what constitutes a good outcome in autoimmune disease and which approach gets you there?
- Protocol design to define initial target indications, strategizing how to rapidly generate early clinical, proof-of-concept data, and differentiating company assets within competitive landscapes
